• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Shanda Interactive Entertainment

Shanda Interactive Entertainment

  1. All
  2. 3rd Party
  3. Investing
  1. Pernix Therapeutics Announces FDA Acceptance With Priority Review of Its TREXIMET® sNDA for Use in Adolescent Patients

    Pernix Therapeutics Announces FDA Acceptance With Priority Review of Its TREXIMET® sNDA for Use in Adolescent Patients

  2. CORRECTING and REPLACING Pernix Therapeutics Exceeds 2014 Revenue Guidance: Delivers FY2014 Net Revenue In Excess of $120 Million

    CORRECTING and REPLACING Pernix Therapeutics Exceeds 2014 Revenue Guidance: Delivers FY2014 Net Revenue In Excess of $120 Million

  3. XenoPort Provides Highlights of HORIZANT Prescription Trends and Update on Development for Alcohol Use Disorder

    XenoPort Provides Highlights of HORIZANT Prescription Trends and Update on Development for Alcohol Use Disorder

  4. U.S. Food and Drug Administration Approves KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation

    U.S. Food and Drug Administration Approves KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation

  5. Ways to Play China's Online Gaming Sector

    Think big if you're serious about investing in virtual fun and games.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.